Arcellx Announces Clinical Hold for its iMMagine-1 Phase 2 Clinical Program ...Middle East

-- FDA has provided clearance to the company to continue dosing patients who have already undergone lymphodepletion -- REDWOOD CITY, Calif., June 19, 2023 /PRNewswire/ -- Arcellx, Inc. (NASDAQ: ACLX), a biotechnology company reimagining cell therapy through the development of innovative...

Hence then, the article about arcellx announces clinical hold for its immagine 1 phase 2 clinical program was published today ( Tuesday 20/06/2023 - 02:52 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Arcellx Announces Clinical Hold for its iMMagine-1 Phase 2 Clinical Program )

Also on site :

• Trump DOJ Refuses to Rule Out Second Amendment Right to Nuclear Weapons
• 53-year-old woman accused of stripping naked and assaulting customers in a Pennsylvania grocery store
• Is Europe heading to an energy crisis?